196 related articles for article (PubMed ID: 32812111)
1. ASO Author Reflections: Real Prevalence of Occult Cancer Cells in Peritoneal Lavage in Patients with Pancreatic Ductal Adenocarcinoma.
Suenaga M; Fujii T
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):893-894. PubMed ID: 32812111
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Positive Status of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: Are They Candidates for Radical Resection?
Kawakatsu S; Shimizu Y; Matsuo K; Hosoda W
Ann Surg Oncol; 2022 Sep; 29(9):5984-5985. PubMed ID: 35441307
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients.
Chattopadhyay A; Wu CH; Tien YW; Lu TP
Ann Surg Oncol; 2022 Mar; 29(3):1616-1617. PubMed ID: 34802101
[No Abstract] [Full Text] [Related]
4. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society.
Tsuchida H; Fujii T; Mizuma M; Satoi S; Igarashi H; Eguchi H; Kuroki T; Shimizu Y; Tani M; Tanno S; Tsuji Y; Hirooka Y; Masamune A; Mizumoto K; Itoi T; Egawa S; Kodama Y; Hamada S; Unno M; Yamaue H; Okazaki K;
Surgery; 2019 Dec; 166(6):997-1003. PubMed ID: 31445763
[TBL] [Abstract][Full Text] [Related]
6. Intraductal papillary mucinous neoplasms of the pancreas.
Fernández-del Castillo C; Adsay NV
Gastroenterology; 2010 Sep; 139(3):708-13, 713.e1-2. PubMed ID: 20650278
[No Abstract] [Full Text] [Related]
7. The "new kid on the block": Intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies.
Adsay NV
Surgery; 2003 May; 133(5):459-63. PubMed ID: 12773972
[No Abstract] [Full Text] [Related]
8. [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method].
Ghothim M; Srovnal J; Bébarová L; Tesaříková J; Skalický P; Klos D; Prokopová A; Vahalíková M; Slavík H; Vrbková J; Neoral Č; Havlík R; Hajdúch M; Loveček M
Rozhl Chir; 2015 Nov; 94(11):464-9; discussion 469. PubMed ID: 26766154
[TBL] [Abstract][Full Text] [Related]
9. ASO Author Reflections: Preceding Systemic Chemotherapy Might Provide Better Prognosis for Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology.
Ariake K; Mizuma M; Motoi F; Unno M
Ann Surg Oncol; 2021 Oct; 28(11):6255-6256. PubMed ID: 33634387
[No Abstract] [Full Text] [Related]
10. SnapShot: pancreatic cancer.
Han H; Von Hoff DD
Cancer Cell; 2013 Mar; 23(3):424-424.e1. PubMed ID: 23518352
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-minority-Serving Hospitals.
Lima HA; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4373-4374. PubMed ID: 36808592
[No Abstract] [Full Text] [Related]
12. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.
Hoffmann K; Kerner C; Wilfert W; Mueller M; Thiery J; Hauss J; Witzigmann H
World J Gastroenterol; 2007 Jan; 13(2):257-63. PubMed ID: 17226905
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.
Loehrer AP; Kinnier CV; Ferrone CR
Adv Surg; 2016 Sep; 50(1):115-28. PubMed ID: 27520867
[No Abstract] [Full Text] [Related]
14. The role of inflammation in pancreatic cancer.
Hausmann S; Kong B; Michalski C; Erkan M; Friess H
Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722
[TBL] [Abstract][Full Text] [Related]
15. ASO Author Reflections: Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.
Zhang SR; Li H; Wang WQ; Liu L; Yu XJ
Ann Surg Oncol; 2018 Dec; 25(13):3994-3995. PubMed ID: 30315385
[No Abstract] [Full Text] [Related]
16. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.
Paniccia A; Hosokawa P; Henderson W; Schulick RD; Edil BH; McCarter MD; Gajdos C
JAMA Surg; 2015 Aug; 150(8):701-10. PubMed ID: 26062046
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Tumor-Infiltrating NETs are New Biomarkers to Predict Postsurgical Survival for Patients with Pancreatic Ductal Adenocarcinoma.
Jin W; Xu HX; Yu XJ; Liu L
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):571-572. PubMed ID: 30710182
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Unlocking the Value of Inpatient Palliative Care for Patients with Pancreatic Cancer.
Kim S; Chervu N; Premji A; Mallick S; Verma A; Ali K; Benharash P; Donahue T
Ann Surg Oncol; 2024 Feb; 31(2):1362-1363. PubMed ID: 38063981
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey.
Pessaux P; Cherkaoui Z
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):773-774. PubMed ID: 32495283
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?
Groot VP; Wolfgang CL; He J
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):806-807. PubMed ID: 30298312
[No Abstract] [Full Text] [Related]
[Next] [New Search]